Verum.de, a full-service contract research organisation (CRO) based in Germany, has opened a US office in Carlsbad, California, extending the reach of its regional expertise in the markets of Central and Eastern Europe (CEE).
The new office will make Verum’s clinical trial services more readily available to clients in the US and North America, the company said.
By conducting studies with Verum in CEE countries, it added, customers will benefit from faster patient enrolment, more affordable trials and “the ease of working with a CRO with regional expertise that practises Western standards for clinical trials and bridges cultural differences”.
Verum has experience in working with American pharmaceutical and biotech companies as well as subcontracting for CROs not present in the CEE region, it noted. It can also provide a full logistical service and help with registering drugs for marketing in the CEE countries.
The privately owned CRO started operating in the CEE region 20 years ago, covering “some countries that were untouched by clinical trials”, it pointed out. Verum now has more than 100 office-based employees working out of eight locations, including its Munich headquarters.
Managing the US office will be Kristi Clark, who takes charge of day-to-day operations, new business acquisitions, project management and marketing. Clark has more than 20 years’ experience in the pharmaceutical industry, including stints at CROs such as Quintiles, Parexel and Synteract.